Deutsche Bank’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-18,217
| Closed | -$597K | – | 4163 |
|
|
2022
Q2 | $597K | Sell |
18,217
-1,005
| -5% | -$31.8K | ﹤0.01% | 2487 |
|
|
2022
Q1 | $505K | Sell |
19,222
-2,151
| -10% | -$52.5K | ﹤0.01% | 2741 |
|
|
2021
Q4 | $507K | Sell |
21,373
-43,098
| -67% | -$1.06M | ﹤0.01% | 2843 |
|
|
2021
Q3 | $1.62M | Sell |
64,471
-30,783
| -32% | -$784K | ﹤0.01% | 2274 |
|
|
2021
Q2 | $2.47M | Sell |
95,254
-5,540
| -5% | -$151K | ﹤0.01% | 2031 |
|
|
2021
Q1 | $2.58M | Sell |
100,794
-31,896
| -24% | -$818K | ﹤0.01% | 1980 |
|
|
2020
Q4 | $2.66M | Sell |
132,690
-35,953
| -21% | -$704K | ﹤0.01% | 1735 |
|
|
2020
Q3 | $2.89M | Sell |
168,643
-3,741
| -2% | -$70.7K | ﹤0.01% | 1533 |
|
|
2020
Q2 | $3.76M | Buy |
172,384
+62,396
| +57% | +$1.43M | ﹤0.01% | 1450 |
|
|
2020
Q1 | $2.54M | Sell |
109,988
-6,352
| -5% | -$185K | ﹤0.01% | 1577 |
|
|
2019
Q4 | $3.84M | Buy |
116,340
+6,428
| +6% | +$206K | ﹤0.01% | 1605 |
|
|
2019
Q3 | $3.5M | Sell |
109,912
-64,600
| -37% | -$1.88M | ﹤0.01% | 1591 |
|
|
2019
Q2 | $4.48M | Sell |
174,512
-164,389
| -49% | -$4.19M | ﹤0.01% | 1885 |
|
|
2019
Q1 | $8.6M | Buy |
338,901
+273,730
| +420% | +$8.17M | 0.01% | 1481 |
|
|
2018
Q4 | $2.21M | Sell |
65,171
-212,386
| -77% | -$6.91M | ﹤0.01% | 2333 |
|
|
2018
Q3 | $9.89M | Buy |
277,557
+91,067
| +49% | +$3.22M | 0.01% | 1644 |
|
|
2018
Q2 | $6.43M | Sell |
186,490
-20,826
| -10% | -$730K | ﹤0.01% | 2105 |
|
|
2018
Q1 | $6.97M | Buy |
207,316
+45,315
| +28% | +$1.43M | ﹤0.01% | 1938 |
|
|
2017
Q4 | $6.19M | Buy |
162,001
+131,730
| +435% | +$5.26M | ﹤0.01% | 1855 |
|
|
2017
Q3 | $1.13M | Sell |
30,271
-130,208
| -81% | -$4.6M | ﹤0.01% | 2925 |
|
|
2017
Q2 | $5.98M | Buy |
160,479
+116,995
| +269% | +$4.23M | ﹤0.01% | 1786 |
|
|
2017
Q1 | $1.71M | Sell |
43,484
-25,759
| -37% | -$966K | ﹤0.01% | 2349 |
|
|
2016
Q4 | $2.41M | Sell |
69,243
-35,767
| -34% | -$1.4M | ﹤0.01% | 2146 |
|
|
2016
Q3 | $4.13M | Sell |
105,010
-71,280
| -40% | -$2.84M | ﹤0.01% | 1872 |
|
|
2016
Q2 | $6.66M | Buy |
176,290
+69,239
| +65% | +$2.32M | ﹤0.01% | 1556 |
|
|
2016
Q1 | $4.11M | Sell |
107,051
-47,569
| -31% | -$1.77M | ﹤0.01% | 1868 |
|
|
2015
Q4 | $7.43M | Buy |
154,620
+3,427
| +2% | +$159K | 0.01% | 1522 |
|
|
2015
Q3 | $5.96M | Sell |
151,193
-65,737
| -30% | -$2.79M | ﹤0.01% | 1676 |
|
|
2015
Q2 | $9.23M | Buy |
216,930
+94,278
| +77% | +$3.76M | 0.01% | 1395 |
|
|
2015
Q1 | $4.84M | Buy |
122,652
+43,557
| +55% | +$1.61M | ﹤0.01% | 1807 |
|
|
2014
Q4 | $2.85M | Buy |
79,095
+9,391
| +13% | +$315K | ﹤0.01% | 2392 |
|
|
2014
Q3 | $2.06M | Sell |
69,704
-94,933
| -58% | -$2.62M | ﹤0.01% | 2513 |
|
|
2014
Q2 | $4.14M | Buy |
164,637
+86,298
| +110% | +$2.13M | ﹤0.01% | 1951 |
|
|
2014
Q1 | $2.02M | Buy |
78,339
+62,336
| +390% | +$1.57M | ﹤0.01% | 2394 |
|
|
2013
Q4 | $359K | Sell |
16,003
-33,057
| -67% | -$638K | ﹤0.01% | 3338 |
|
|
2013
Q3 | $694K | Buy |
49,060
+21,969
| +81% | +$294K | ﹤0.01% | 3247 |
|
|
2013
Q2 | $368K | Buy |
+27,091
| New | +$369K | ﹤0.01% | 3361 |
|
Other funds holding NTUS
Deutsche Bank's NTUS Position: Q3 2022 in Review
Deutsche Bank sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 18,217 shares — an estimated $597K sold.
Deutsche Bank first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $9.89M in Q3 2018. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Deutsche Bank reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Deutsche Bank sold 18,217 Natus Medical Inc shares in Q3 2022, an estimated $597K.
- Deutsche Bank first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
- Deutsche Bank's Natus Medical Inc position peaked at $9.89M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Deutsche Bank's 13F filing for Q3 2022, filed 14 Nov 2022.